Consensus Avadel Pharmaceuticals plc

Equities

AVDL

IE00BDGMC594

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-19 pm EDT			5-day change	1st Jan Change
17.33 ^USD	-0.29%		+8.38%	+22.73%

Apr. 17	European Equities Traded in the US as American Depositary Receipts Trend Lower in Wednesday Trading	MT
Apr. 16	European Equities Traded in the US as American Depositary Receipts Lower in Tuesday Trading	MT

Evolution of the average Target Price on Avadel Pharmaceuticals plc

Price target over the last 5 years

History of analyst recommendation changes

060bbd67c804f044ee53b280007f.W__sT3vGArpOqtbddYjzbj-XWGIm-7jbHBmyQdL4hC0.bM-JF0rxTf8R6Z6IDO2JGlDYMRJlrMCSdXzkLLmO0kYsnY0HDodujiv8sQ~b6d91824693e1fe2cf78ef2b61f640c4

Analyst Recommendations on Avadel Pharmaceuticals plc

Craig-Hallum Adjusts Avadel Pharmaceuticals' Price Target to $22 From $20, Maintains Buy Rating	Mar. 05	MT
HC Wainwright Raises Price Target on Avadel Pharmaceuticals to $25 From $21, Maintains Buy Rating	Mar. 05	MT
Piper Sandler Raises Price Target on Avadel Pharmaceuticals to $23 From $18, Maintains Overweight Rating	Mar. 05	MT
Needham Adjusts Avadel Pharmaceuticals' Price Target to $22 From $20, Keeps Buy Rating	Mar. 05	MT
Oppenheimer Adjusts Avadel Pharmaceuticals Price Target to $29 From $27, Maintains Outperform Rating	Mar. 05	MT
UBS Initiates Avadel Pharmaceuticals With Buy Rating, $21 Price Target	Feb. 06	MT
Oppenheimer Raises Price Target on Avadel Pharmaceuticals to $27 From $25, Maintains Outperform Rating	Jan. 09	MT
Needham Adjusts Price Target on Avadel Pharmaceuticals to $20 From $19, Keeps Buy Rating	Dec. 20	MT
HC Wainwright Adjusts Avadel Pharmaceuticals Price Target to $21 From $17.50, Maintains Buy Rating	23-07-05	MT
Oppenheimer Adjusts Avadel Pharmaceuticals Price Target to $25 From $22, Maintains Outperform Rating	23-06-30	MT
Ladenburg Thalmann Adjusts Price Target on Avadel Pharmaceuticals to $16 From $14.50, Maintains Buy Rating	23-05-02	MT
HC Wainwright Adjusts Price Target on Avadel Pharmaceuticals to $17.50 From $14, Maintains Buy Rating	23-05-02	MT
Needham Adjusts Price Target on Avadel Pharmaceuticals to $14 From $12, Maintains Buy Rating	23-05-02	MT
Oppenheimer Adjusts Avadel Pharmaceuticals Price Target to $22 From $20, Maintains Outperform Rating	23-05-02	MT
Possibility of US Fed's Rate Hike Pause Supports American Depositary Receipts of European Equities	23-03-23	MT
HC Wainwright Adjusts Price Target on Avadel Pharmaceuticals to $14 From $13, Keeps Buy Rating	23-03-23	MT
American Depositary Receipts of European Equities Advance Slightly Before US Rate Decision	23-03-22	MT
Oppenheimer Adjusts Avadel Pharmaceuticals' Price Target to $20 From $19, Maintains Outperform Rating	23-02-27	MT
ECB, Bank of England Interest Rate Hikes Weigh Down European Equities	22-12-15	MT
Jefferies Upgrades Avadel Pharmaceuticals to Buy From Hold, Raises Price Target to $11 From $6.50	22-11-30	MT
Needham Adjusts Price Target on Avadel Pharmaceuticals to $9 From $8, Maintains Buy Rating	22-11-21	MT
Oppenheimer Adjusts Avadel Pharmaceuticals Price Target to $19 From $15, Maintains Outperform Rating	22-11-21	MT
European Equities Follow US Markets Lower on Interest Rate Concerns	22-11-17	MT
Oppenheimer Adjusts Avadel Pharmaceuticals Price Target to $15 From $13, Maintains Outperform Rating	22-11-11	MT
SVB Securities Adjusts Price Target on Avadel Pharmaceuticals to $12 From $6, Keeps Outperform Rating	22-08-11	MT